Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke

Q Xu, B Zhao, Y Ye, Y Li, Y Zhang, X Xiong… - Journal of …, 2021 - Springer
The nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) family pyrin
domain-containing 3 (NLRP3) inflammasome is a member of the NLR family of inherent …

NLRP3 inflammasome: a promising target in ischemic stroke

L Gao, Q Dong, Z Song, F Shen, J Shi, Y Li - Inflammation Research, 2017 - Springer
Background Recently, several studies have demonstrated that the NLRP3 inflammasome
participates in detecting cellular damage and mediating inflammatory responses to aseptic …

NLRP3 inflammasome in ischemic stroke: as possible therapeutic target

M Alishahi, M Farzaneh… - … Journal of Stroke, 2019 - journals.sagepub.com
Inflammation is a devastating pathophysiological process during stroke, a devastating
disease that is the second most common cause of death worldwide. Activation of the NOD …

Inhibition of NLRP3 inflammasome: a prospective target for the treatment of ischemic stroke

YS Feng, ZX Tan, MM Wang, Y Xing, F Dong… - Frontiers in Cellular …, 2020 - frontiersin.org
Stroke is one of the major devastating diseases with no effective medical therapeutics.
Because of the high rate of disability and mortality among stroke patients, new treatments …

Molecular mechanisms of inflammasome in ischemic stroke pathogenesis

MG Puleo, S Miceli, T Di Chiara, GM Pizzo… - Pharmaceuticals, 2022 - mdpi.com
Ischemic stroke (also called cerebral ischemia) is one of the leading causes of death and
severe disability worldwide. NLR inflammasomes play a crucial role in sensing cell damage …

NLRP3 inflammasome in the pathophysiology of hemorrhagic stroke: a review

Y Luo, C Reis, S Chen - Current neuropharmacology, 2019 - ingentaconnect.com
Hemorrhagic stroke is a devastating disease with high morbidity and mortality. There is still a
lack of effective therapeutic approach. The recent studies have shown that the innate …

NLRP3 inflammasome activation: a therapeutic target for cerebral ischemia–reperfusion injury

L Wang, W Ren, Q Wu, T Liu, Y Wei, J Ding… - Frontiers in Molecular …, 2022 - frontiersin.org
Millions of patients are suffering from ischemic stroke, it is urgent to figure out the
pathogenesis of cerebral ischemia–reperfusion (I/R) injury in order to find an effective cure …

The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target

WT O'Brien, L Pham, GF Symons, M Monif… - Journal of …, 2020 - Springer
There is a great clinical need to identify the underlying mechanisms, as well as related
biomarkers, and treatment targets, for traumatic brain injury (TBI). Neuroinflammation is a …

Evidence that NF-κB and MAPK signaling promotes NLRP inflammasome activation in neurons following ischemic stroke

DYW Fann, YA Lim, YL Cheng, KZ Lok… - Molecular …, 2018 - Springer
Multi-protein complexes, termed “inflammasomes,” are known to contribute to neuronal cell
death and brain injury following ischemic stroke. Ischemic stroke increases the expression …

NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes

P Hong, RN Gu, FX Li, XX Xiong, WB Liang… - Journal of …, 2019 - Springer
The NLRP3 (nucleotide-binding oligomerization domain-like receptor [NLR] family pyrin
domain-containing 3) inflammasome is a member of the NLR family of innate immune cell …